DASATINIB ENHANCES ANTHRACYCLIN-BASED CHEMOTHERAPY IN PRE-CLINICAL MODELS OF T-CELL LYMPHOMA

EHA Library, Cristiana Carniti, 215081

ELEVATED SERUM IL-8, IL-10, IL-22, AND MCP-1 ARE ASSOCIATED WITH INFERIOR CLINICAL OUTCOMES IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA

EHA Library, Jun Ho Yi, 215082

BIOMARKER ANALYSES OF PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, FOLLICULAR LYMPHOMA, OR RICHTER’S TRANSFORMATION TREATED WITH IBRUTINIB + NIVOLUMAB IN THE PHASE 1/2A LYM1002 STUDY

EHA Library, Anas Younes, 215083

SYSTEMS BIOLOGY ANALYSIS OF RESPONSIVENESS OF NON-HODGKIN LYMPHOMA B-CELL LINES TO CD37 TARGETING RADIOIMMUNOTHERAPY

EHA Library, Sebastian Patzke, 215084

CBL-MZ IS NOT A SINGLE BIOLOGICAL ENTITY: EVIDENCE FROM GENOMIC ANALYSIS AND PROLONGED CLINICAL FOLLOW UP

EHA Library, Jonathan Strefford, 215085

HETEROGENEOUS MUTATIONS AT RHOA EXON 2 REVEALED BY TARGETED SEQUENCING OF CELL FREE DNA AND PERIPHERAL BLOOD MONONUCLEAR CELL DNA IN PERIPHERAL T-CELL LYMPHOMA

EHA Library, Simon D Wagner, 215086

PROGRAMMED DEATH-1 PATHWAY UP-REGULATION BY LENALIDOMIDE IN ACTIVATED LOW-GRADE LYMPHOMA CELLS

EHA Library, Fortunato Morabito, 215087

THE EFFECT OF DUVELISIB, A DUAL INHIBITOR OF PI3K-DELTA,GAMA ON COMPONENTS OF THE TUMOR MICROENVIRONMENT IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Carla Casulo, 215088

INCORPORATION OF GENE EXPRESSION PROFILING FOR CELL-OF-ORIGIN DETERMINATION USING FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUE SECTIONS IN ROUTINE WORK-UP OF DIFFUSE LARGE B-CELL LYMPHOMA CASES

EHA Library, Ryan S. Robetorye, 215089

DIFFUSE LARGE B CELL LYMPHOMA WITH CONCORDANT BONE MARROW INVOLVEMENT. UTILITY OF FLOW CYTOMETRY, CLINICAL AND BIOLOGICAL EVALUATION.

EHA Library, Lucia Morais, 215090

DUVELISIB INHIBITION OF CHEMOKINES IN PATIENTS WITH CLL AND INHL

EHA Library, David Weaver, 215091

ACCURATE GCB/ABC CLASSIFICATION OF DE NOVO DIFFUSE LARGE B-CELL LYMPHOMA WITH ABERRANT CD10+ MUM1+ PHENOTYPE BY RT-MLPA

EHA Library, Yannick Le Bris, 215092

IMMUNOGLOBULIN KAPPA DELETING ELEMENT (IGK-KDE) REARRANGEMENTS AS POSSIBLE TARGET FOR MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN MANTLE CELL LYMPHOMA (MCL)

EHA Library, Irene Della Starza, 215093

CIRCULATING MICRORNAS (MIRNAS) IN ITP PATIENTS BEFORE AND AFTER TREATMENT WITH THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS)–DIAGNOSTIC AND PROGNOSTIC VALUE

EHA Library, Lamya Garabet, 215094

A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Michael Tarantino, 215095

THE BURDEN OF DISEASE AND IMPACT OF IMMUNE THROMBOCYTOPENIA (ITP) ON PATIENT QUALITY OF LIFE AND PRODUCTIVITY: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)

EHA Library, Nichola Cooper, 215096

FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Michael Tarantino, 215097

AVATROMBOPAG DEMONSTRATES SUPERIORITY TO PLACEBO FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA IN A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

EHA Library, Wojciech Jurczak, 215098

A PHASE 1B, OPEN-LABEL, DOSE-ESCALATION STUDY OF PRTX-100, A HIGHLY PURIFIED FORM OF STAPHYLOCOCCAL PROTEIN A (SPA), IN ADULT PATIENTS WITH PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Nichola Cooper, 215099

RITUXIMAB IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: STANDARD DOSE VERSUS LOW DOSE

EHA Library, Saikat Datta, 215100

SAFETY PROFILE OF CAPLACIZUMAB DURING THE PHASE III HERCULES STUDY: FREQUENCY OF ADVERSE EVENTS ACCORDING TO STUDY PERIOD

EHA Library, Filip Callewaert, 215101

LOW-DOSE RITUXIMAB PLUS PREDNISOLONE YIELDS HIGHER SUSTAINED RESPONSE RATES THAN PREDNISOLONE MONOTHERAPY AS FRONTLINE THERAPY IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Saikat Datta, 215102

EXTENDED FOLLOW UP OF PATIENTS TREATED IN THE RITUXIMAB AS SECOND-LINE TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA – THE RITP STUDY

EHA Library, Waleed Ghanima, 215103

EPIDEMIOLOGY AND MANAGEMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: REAL WORLD DATA FROM THE UK ITP REGISTRY

EHA Library, Abbas Zaidi, 215104

PREDICTORS OF SUCCESS FOR SPLENECTOMY IN CHILDHOOD AUTOIMMUNE CYTOPENIA

EHA Library, Nathalie Aladjidi, 215105

PHASE II, MULTIPLE-DOSE STUDY OF ANTI-FCRN ANTIBODY, ROZANOLIXIZUMAB (UCB7665), IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: SECOND INTERIM ANALYSIS

EHA Library, Tadeusz Robak, 215106

SWI IDENTIFIES BRAIN MICROHAEMORRHAGES IN ASYMPTOMATIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Camelia Vladescu, 215107

DEFINING TREATMENT SUCCESS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA RECEIVING THROMBOPOIETIN RECEPTOR AGONIST THERAPY: RESULTS FROM A MODIFIED DELPHI CONSENSUS PANEL

EHA Library, Anuja Roy, 215108

MYH9-RELATED THROMBOCYTOPENIA: FOUR NOVEL VARIANTS AFFECTING THE TAIL DOMAIN OF THE NON-MUSCLE MYOSIN HEAVY CHAIN IIA ASSOCIATE WITH A MILD CLINICAL EVOLUTION OF THE DISEASE

EHA Library, Carlo Zaninetti, 215109

REAL-WORLD TAPERING AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONIST THERAPY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SURVEY OF HEMATOLOGISTS IN THE UNITED KINGDOM

EHA Library, Anuja Roy, 215110

ELTROMBOPAG TREATMENT IN PATIENTS WITH PERSISTENT VERSUS CHRONIC IMMUNE THROMBOCYTOPENIA: COMPARISON OF EFFICACY AND SAFETY RESULTS FROM THE PHASE III EXTEND STUDY AND A PHASE IV STUDY

EHA Library, Raymond Wong, 215111

PERFORMANCE OF THE ISTH BLEEDING ASSESSMENT TOOL IN PREDICTING THE PRESENCE OF INHERITED PLATELET FUNCTION DISORDERS

EHA Library, Maaike Blaauwgeers, 215112

SPLENECTOMY IN COMPARISON WITH RITUXIMAB AS A SECOND LINE TREATMENT FOR RELAPSED OR REFRACTORY ITP

EHA Library, Martina Morić-Perić, 215113

IMMUNE THROMBOCYTOPENIA PURPURA (ITP) PATIENT JOURNEY – ROUTINE CLINICAL CARE FOR CHRONIC ITP IN DENMARK, 2009-2015

EHA Library, Henrik Frederiksen, 215114

DISEASE MANAGEMENT OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA - RESULTS OF A REPRESENTATIVE RETROSPECTIVE SURVEY IN GERMANY

EHA Library, Anne Sophie Kubasch, 215115

PREDICTIVE FACTORS FOR SUCCESSFUL SPLENECTOMY OUTCOME – SYSTEMATIC REVIEW

EHA Library, Mirjana Mitrovic, 215116

CARDIOVASCULAR AND BLEEDING OUTCOMES IN A NORDIC COHORT OF ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP)

EHA Library, Kasper Adelborg, 215117

PLATELET COUNT EVOLUTION AS A PREDICTOR OF OUTCOME AFTER RITUXIMAB TREATMENT IN CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Shixuan Wang, 215118

SUSTAINED PLATELET COUNTS ≥100X109/L DURING ELTROMBOPAG TREATMENT IN PATIENTS WITH PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA (ITP): RESULTS FROM A 2-YEAR, PHASE IV, OPEN-LABEL STUDY

EHA Library, Tahir Shamsi, 215119

LONG-TERM EFFICACY AND SAFETY OF ROMIPLOSTIM FOR TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA

EHA Library, Sergey Semochkin, 215120

ITP SECONDARY TO ALEMTUZUMAB-INDUCED RENAL TRANSPLANT: OUTCOME OF 31 PATIENTS

EHA Library, Elisa Lucchini, 215121

AN OBSERVATIONAL, NON-INTERVENTIONAL CLINICAL PRACTICE STUDY OF ROMIPLOSTIM IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA (ITP) – PLATON FINAL RESULTS

EHA Library, Barbara Skopec, 215122

COMBINED/CONCOMITANT THERAPY FOR RAPID RECOVERY IN PATIENTS WITH REFRACTORY/RECURRENT IMMUNE THROMBOCYTOPENIA (ITP) AND MODERATE/SEVERE BLEEDING: AN OBSERVATIONAL STUDY

EHA Library, Mariasanta Napolitano, 215123

BRENTUXIMAB VEDOTIN IN RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE-CELL LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS

EHA Library, Lung-I Cheng, 215124

REAL-WORLD OUTCOMES ASSOCIATED WITH LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE IN THE TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA WITHOUT STEM CELL TRANSPLANT

EHA Library, Ajai Chari, 215125

CPX-351 FOR THE TREATMENT OF NEWLY DIAGNOSED, THERAPY-RELATED ACUTE MYELOID LEUKEMIA (TAML) OR AML WITH MYELODYSPLASIA-RELATED CHANGES (AML-MRC): NUMBER NEEDED TO TREAT (NNT) TO PREVENT ONE DEATH

EHA Library, Arthur Louie, 215126

QUALITY OF LIFE IN NEWLY DIAGNOSED AND RELAPSED DANISH MULTIPLE MYELOMA PATIENTS - A NATIONAL LONGITUDINAL STUDY OF DANISH MYELOMA STUDY GROUP

EHA Library, Lene Kongsgaard Nielsen, 215127

COMBINED VISIBLE AND INFRA RED LOW LEVEL LASER THERAPY FOR PREVENTION OF ORAL MUCOSITIS IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Mehdi Tabarraei, 215128

IMPACT OF CLINICAL AND SOCIAL FACTORS ON QUALITY OF LIFE (QOL) IN PATIENTS (PTS) WITH TRANSFUSION-DEPENDENT (TDT) AND NON-TRANSFUSION-DEPENDENT (NTDT) BETA-THALASSEMIA: A MULTICENTER STUDY

EHA Library, Vip Viprakasit, 215129

RAPID AND COMPREHENSIVE GENOMIC CHARACTERIZATION OF HEMATOLOGICAL MALIGNANCIES USING A HYBRID-CAPTURE TARGETED SEQUENCING PANEL

EHA Library, Michaela Gruber, 215130

UNTANGLING HOSPITALIZATIONS IN SYSTEMIC AMYLOIDOSIS: PATIENT CHARACTERISTICS, ECONOMIC COST AND CLINICAL OUTCOMES

EHA Library, Tiffany P. Quock, 215131

ERECTILE DISFUNCTION IN HEMATOLOGICAL MALIGNANCIES

EHA Library, Frosina Krstanoska, 215132

THE BURDEN OF DISEASE IN PYRUVATE KINASE DEFICIENCY: PATIENTS’ PERCEPTION OF THE IMPACT ON HEALTH-RELATED QUALITY OF LIFE

EHA Library, Sam Salek, 215133

RELEVANT REDUCTION OF POMALIDOMIDE-RELATED NEUTROPENIA BY INTENSIVE USE OF MYELOID GROWTH FACTOR

EHA Library, MARINA PARISI, 215134

REAL WORLD EVIDENCE BASED COST-EFFECTIVENESS ANALYSES (CEA) OF NILOTINIB VERSUS IMATINIB AS FIRST-LINE TREATMENT IN THE MANAGEMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN CHINA

EHA Library, Ming Jian, 215135

LIVING AND COPING WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A QUALITATIVE STUDY OF GREEK PATIENTS’ EXPERIENCES ON BEHALF OF ERIC, THE EUROPEAN RESEARCH INITIATIVE ON CLL

EHA Library, Aliki Xochelli, 215136

COMPARISON OF THE PAPER-BASED AND ELECTRONIC VERSION OF A NEW PATIENT-REPORTED OUTCOME MEASURE IN HAEMATOLOGICAL MALIGNANCY FOR USE IN CLINICAL PRACTICE, HM-PRO: AN EQUIVALENCE STUDY

EHA Library, Pushpendra Goswami, 215137

A SEER-MEDICARE ANALYSIS OF NOVEL TREATMENT USE AND ASSOCIATED OUTCOMES AMONG AFRICAN AMERICAN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Sikander Ailawadhi, 215138

USE OF PATIENT-CENTRED OUTCOMES IN THE MANAGEMENT OF ANEMIA: A SYSTEMATIC REVIEW

EHA Library, Phillip Staibano, 215139

COST UTILITY ANALYSIS OF THE USE OF LETERMOVIR FOR THE PROPHYLAXIS OF CYTOMEGALOVIRUS IN PATIENTS UNDERGOING ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT – TWO SCENARIO ANALYSES FROM ITALY

EHA Library, Fabio Ciceri, 215140

ERN-EUROBLOODNET: THE EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES. 1ST YEAR OF IMPLEMENTATION

EHA Library, María del Mar Mañú Pereira, 215141

PALLIATIVE CARE INDICATION IN NON-HODGKIN'S LYMPHOMA PATIENTS: A COMPARISON TO SOLID TUMOR PATIENTS

EHA Library, Lucia Morais, 215142

EVALUATING THE CORRELATION BETWEEN FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND TREATED WITH BIOSIMILAR EPOETIN ALFA FOR CHEMOTHERAPY-INDUCED ANEMIA: THE CIROCO STUDY

EHA Library, Kamel Laribi, 215143

DIAGNOSIS DISCLOSURE IN PATIENTS WITH HEMATOLOGICAL CANCERS IN INDIA

EHA Library, Chepsy Philip, 215144

NATIONAL EVALUATION OF QUALITY OF CARE DURING THE 5 FIRST YEARS OF LIFE FOR CHILDREN DIAGNOSED BY THE NEWBORN SICKLE CELL SCREENING PROGRAMME IN FRANCE: RESULTS OF EVADREP STUDY

EHA Library, isabelle Thuret, 215145

VISUAL CORTEX CHANGES IN CHILDREN WITH SICKLE CELL DISEASE: A MULTIMODAL MRI STUDY

EHA Library, R Colombatti, 215146

RESULTS FROM A PHASE 2A STUDY (GBT440-007) EVALUATING ADOLESCENTS WITH SICKLE CELL DISEASE TREATED WITH MULTIPLE DOSES OF VOXELOTOR (GBT440), A HBS POLYMERIZATION INHIBITOR

EHA Library, Clark Brown, 215147

EVALUATION OF CEREBRAL TISSUE OXYGENATION USING NIRS DURING TRANSFUSION EXCHANGES IN SICKLE CELL PATIENTS WITH CEREBRAL VASCULOPATHY.

EHA Library, Pablo Bartolucci, 215148

COMPASSIONATE-USE VOXELOTOR (GBT440) FOR PATIENTS WITH SEVERE SICKLE CELL DISEASE (SCD) AND LIFE-THREATENING COMORBIDITIES

EHA Library, Kenneth Bridges, 215149

CRIZANLIZUMAB TREATMENT IS NOT ASSOCIATED WITH THE DEVELOPMENT OF PROTEINURIA AND HEMATURIA IN PATIENTS WITH SICKLE CELL DISEASE: A SAFETY ANALYSIS FROM THE SUSTAIN STUDY

EHA Library, Kenneth Ataga, 215150

PHARMACOKINETICS (PK) OF VOXELOTOR (GBT440) USING POPULATION PHARMACOKINETIC (PPK) AND PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING IN PEDIATRIC SUBJECTS WITH SICKLE CELL DISEASE (SCD)

EHA Library, Carla Washington, 215151

ACCESS TO EMERGENCY DEPARTMENT AND IDENTIFICATION OF SUBJECTS WITH SICKLE CELL DISEASE AND OTHER HEMOGLOBINOPATHIES IN REFUGEES

EHA Library, Lucia De Franceschi, 215152

AN ANALYSIS OF PAIN CRISIS PATTERNS IN DIFFERENT GEOGRAPHIC REGIONS OF THE WORLD: ANALYSIS FROM THE CASIRE STUDY.

EHA Library, Raffaella Colombatti, 215153

CHARACTERISTICS OF EPISODES OF ACUTE CHEST SYNDROME IN ADULTS PATIENTS WITH SICKLE CELL DISEASE IN GUADELOUPE AND PREDICTIVE FACTORS OF SEVERITY: A RETROSPECTIVE STUDY

EHA Library, Maryse Etienne-Julan, 215154

COULD LIVER INVOLVEMENT BE EARLY DETECTED IN SICKLE CELL DISEASE?

EHA Library, Marta Bortolotti, 215155

SAFETY AND IMPROVED SUSTAINED RESPONSE RATES IN PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE TREATED WITH IBRUTINIB: 1-YEAR UPDATE OF A PHASE 1B/2 STUDY

EHA Library, Edmund Waller, 215156

SINGLE CORD BLOOD UNIT PLUS THIRD PARTY DONOR CELLS (HAPLO-CORD) TRANSPLANTATION COMPARED TO ADULT UNRELATED DONORS IN PATIENTS WITH ACUTE LEUKEMIA: A RETROSPECTIVE CASE-CONTROL STUDY

EHA Library, Guiomar BAUTISTA CARRASCOSA, 215157

CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE INDUCTION AND SALVAGE ASCT IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA WITH FIRST RELAPSE AFTER UPFRONT ASCT

EHA Library, Henrik Gregersen, 215158

THE ROLE OF COLLATERAL RELATED DONORS IN HAPLOIDENTICAL HEMATOPOIETIC TRANSPLANTATION: A COMPARATIVE STUDY BETWEEN COLLATERAL RELATED DONORS AND PARENTAL DONORS.

EHA Library, Xiao-Dong Mo, 215159

EFFICACY OF BONE MARROW DERIVED MSC FOR STEROID REFRACTORY ACUTE GVHD ASSOCIATES WITH AGE AND A DEFINED MOLECULAR PROFILE OF MSC DONORS

EHA Library, Lotte van der Wagen, 215160

PROGNOSTIC INDEX FOR PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA WHO UNDERWENT HEMATOPOIETIC CELL TRANSPLANTATION: A KSGCT MULTICENTER ANALYSIS

EHA Library, Takayoshi Tachibana, 215161

IMPROVED SURVIVAL FOLLOWING OMS721 TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HCT-TMA)

EHA Library, Alessandro Rambaldi, 215162

TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY: INCIDENCE, PROGNOSTIC FACTORS, MORBIDITY AND MORTALITY IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Eleni Gavriilaki, 215163

PHASE II STUDY EVALUATING THE SAFETY AND EFFICACY OF BL-8040 FOR THE MOBILIZATION OF DONOR HEMATOPOIETIC STEM CELLS AND ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES

EHA Library, Michael Rettig, 215164

NON-HLA MATCHED, EX-VIVO EXPANDED CORD BLOOD PRODUCT SIGNIFICANTLY IMPROVES THE KINETICS OF HEMATOPOIETIC RECOVERY AND RESULTS IN EXCELLENT SURVIVAL IN PATIENTS UNDERGOING CORD BLOOD TRANSPLANTATION

EHA Library, Filippo Milano, 215165

INCIDENCE AND RISK FACTORS OF ANTIBODIES TO HUMAN LEUKOCYTE ANTIGENS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION CANDIDATES: A MULTI-CENTER STUDY

EHA Library, Ying-Jun Chang, 215166

SAFETY AND EFFICACY OF VEDOLIZUMAB IN PATIENTS WITH STEROID REFRACTORY ACUTE GASTROINTESTINAL GRAFT-VERSUS-HOST DISEASE: A RETROSPECTIVE CHART REVIEW

EHA Library, Aliki Taylor, 215167

COMPARISON OF MOBILIZED PERIPHERAL BLOOD STEM CELLS VERSUS BONE MARROW HAPLOIDENTICAL TRANSPLANTATION USING POST-TRANSPLANT CYCLOPHOSPHAMIDE: A RETROSPECTIVE STUDY OF SFGM-TC IN 176 PATIENTS

EHA Library, Nathalie JACQUE, 215168

G-CSF/ATG-BASED REGIMEN IS SUPERIOR TO PTCY-BASED REGIMEN IN TERMS OF ENGRAFTMENT AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

EHA Library, Xiao-Jun Huang, 215169

BENDA-BEAM HIGH-DOSE THERAPY PRIOR TO AUTO-SCT IS EFFECTIVE IN RESISTANT/RELAPSED DLBCL: A PHASE II MULTICENTRIC STUDY.

EHA Library, Giuseppe Visani, 215170

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROME AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOID NEOPLASMS: RETROSPECTIVE STUDY OF SFGM-TC

EHA Library, Daniel Jaimes-Albornoz, 215171

A PHASE I/II STUDY OF PEGYLATED-INTERFERON-2ALPHA FOR RELAPSED HAEMATOLOGICAL MALIGNANCY AFTER ALLOGENEIC HAEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION

EHA Library, Andrea Henden, 215172

OUTCOME OF MESENCHYMAL STROMAL CELL TREATMENT IN CHRONIC GVHD PREDICTED BY THYMIC FUNCTION: A PHASE II CLINICAL STUDY

EHA Library, Erik Boberg, 215173

IMPAIRED BONE MARROW ENDOTHELIAL PROGENITOR CELLS ARE INVOLVED IN THE PATHOGENESIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOTRANSPLANT

EHA Library, Xie-Na Cao, 215174

PHASE II PROSPECTIVE STUDY OF DIFFERENT ATG DOSING IN ADDITION TO STANDARD HAPLOIDENTICAL TRANSPLANT CONDITIONING WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY)

EHA Library, Mona Hassanein, 215175

EXTENSIVE TELOMERE SHORTENING IN MONONUCLEAR CELLS IS ASSOCIATED WITH INFERIOR OVERALL SURVIVAL AFTER NON-MYELOABLATIVE ALLO-HCT

EHA Library, Jens Helby Petersen, 215176

G-CSF MOBILIZED MACROPHAGES POLARIZATION MAY PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qi Wen, 215177

INTERFERON-Α IS EFFECTIVE FOR TREATMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH T(8;21) ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Dong Mo, 215178

EFFICACY AND SAFETY OF AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN ELDERLY MULTIPLE MYELOMA (MM) PATIENTS AGED ≥ 65 YEARS: A SINGLE CENTRE EXPERIENCE

EHA Library, David Routledge, 215179

PD-1 CONTRIBUTES TO THE DEVELOPMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE IN PEDIATRIC PATIENTS RECEIVING HAPLOIDENTICAL STEM CELL TRANSPLANTATION

EHA Library, Ari Ahn, 215180